Ilan Zipkin

Ilan Zipkin is an accomplished leader in the biotechnology sector, currently serving as Founder and CEO of Supercede Therapeutics Inc. since August 2023 and as Venture Partner at Breakout Ventures since March 2024. Prior to these roles, Zipkin held the position of Partner and VP of Business Development and Licensing at Aditum Bio, focusing on the in-licensing and clinical development of therapeutics, from September 2019 to August 2023. Ilan founded Supercede Ventures in December 2016, providing biotechnology startup strategy and advisory services until September 2019. Additional experience includes serving as Vice President of Business Development at the Parker Institute for Cancer Immunotherapy and as Senior Investment Director at Takeda Ventures, Inc. Earlier career roles encompassed partnerships at Prospect Venture Partners and MPM Capital, as well as a position as Science Editor at BioCentury Publications. Education includes a Ph.D. in Cell Biology and Biochemistry from the University of California, San Francisco, and a Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley.